1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Aravive Inc (ARAV)
  7. Quote


Aravive Stock Price

0.08 (2.17%)
Volume 54,713
Bid Price 3.62
Ask Price 3.76
News -
Day High 3.79


52 Week Range


Day Low 3.62
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aravive Inc ARAV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.08 2.17% 3.76 16:30:00
Open Price Low Price High Price Close Price Prev Close
3.67 3.62 3.79 3.76 3.68
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
532 54,713 $ 3.70 $ 202,694 - 3.47 - 9.95
Last Trade Time Type Quantity Stock Price Currency
16:55:45 31 $ 3.76 USD


Draw Mode:

Aravive Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 77.88M 20.71M 14.90M $ 5.69M $ - -1.94 -2.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 221.72k 18.40%

more financials information »

Aravive News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARAV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.563.86993.523.7444,0010.205.62%
1 Month3.954.323.473.7698,047-0.19-4.81%
3 Months4.344.56393.473.9690,446-0.58-13.36%
6 Months5.186.943.475.29348,882-1.42-27.41%
1 Year5.079.953.475.75270,272-1.31-25.84%
3 Years6.5029.603.077.59188,795-2.74-42.15%
5 Years6.5229.603.077.59188,445-2.76-42.33%

Aravive Description

Aravive Inc is a clinical-stage biotechnology company. It focuses on developing therapies that target important survival pathways for both solid tumors as well as hematologic malignancies. The company's lead candidate AVB-500 is developed as a targeted therapy against ovarian cancer.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.